Review article · 2019
Review articlePublished 2017
Anticancer Agents in Combination with Statins
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Statins are 3-Hydroxy-3-methylgutaryl CoA (HMG CoA) reductase inhibitors and mainly used in cardiovascular diseases. However, they are also widely known for their anticancer activities mediated by antiproliferative, proapoptotic, anti-invasive, and radio sensitizing properties. They are tested alone in several clinical trials for their anticancer activity and the response in not satisfactory due to high dose requirements in humans. Tumor inhibitory concentration of statins is 10-100 μM for different cancer cell lines when tested in vitro. But statins can cause anorexia and death in some individuals if concentration is reached to 20-25 μM in serum. So, there is high risk factor. To avoid these unwanted harmful effects, we can give statins in combination with other chemotherapeutic drugs for synergism. It will reduce the concentration of statins in dosage, and can avoid unwanted toxic effects. When used along with the other chemo therapeutic agents like prenylation inhibitors, NSAIDS and standard chemotherapeutic agents, they have shown much better results at lower doses with little or no toxicity.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2020
Combination Therapy of Eurycomanone and Doxorubicin As Anticancer on T47D and MCF-7 Cell Lines
Conference abstract · 16 Apr 2018
Combination of (1,2-epoxy-3(3-(3,4-dimetoxyphenyl)-4H-1-benzopyran-4on) propane with doxorubicin and cisplatin synergistically augments anticancer activity by increasing miRNA-214, miRNA-34 and p53 expression
Article · 10 Jun 2025
Plant-Derived Anticancer Agents: A Sustainable Approach to Combating Cancer
Commentary · 27 Dec 2024
Pharmacognosy of Plant-Based Cancer Therapies: Unlocking the Mechanisms Behind Natural Anticancer Agents
More from this journal
The newest in Journal of Bioequivalence & Bioavailability.
Article · 5 Oct 2026
Long COVID in pediatric and young adult patients: a review of evaluation for microvascular changes, endothelial dysfunction, and arterial stiffness
Article · 12 Jun 2026
Advances in Bioavailability Through Innovative Drug Delivery Systems and Formulation Technologies
Article · 12 Jun 2026
Bioequivalence Study Design and Methodological Approaches in Generic Drug Evaluation
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioequivalence & Bioavailability
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Mohammad Adnan”
- BylineArticles whose byline prints “Kabir Imtiazul Mohammad”
- BylineArticles whose byline prints “Mohammad Emdad Hossain Manik”
